Thaher, Firas <br/><br/>
Differential effects of the tumor necrosis factor alpha-blocker infliximab and etanercept on immunocompetent cells in vitro.  [electronic resource] 

 -  International immunopharmacology  Nov 2011 
 - 1724-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-1705 
<br/><br/><label>Standard No.: </label>10.1016/j.intimp.2011.06.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--pharmacology<br/>Cell Proliferation--drug effects<br/>Cytokines--antagonists & inhibitors<br/>Cytotoxicity, Immunologic--drug effects<br/>Dose-Response Relationship, Drug<br/>Etanercept<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Immunoglobulin G--pharmacology<br/>Infliximab<br/>Macrophages--drug effects<br/>Male<br/>Natural Killer T-Cells--drug effects<br/>Receptors, Tumor Necrosis Factor<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors<br/>Young Adult